Here's how DEGRUYTERBRILL.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

DEGRUYTERBRILL . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Degruyterbrill.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. Social Networks
  11. External Links
  12. Analytics And Tracking
  13. Libraries
  14. Hosting Providers

We are analyzing https://www.degruyterbrill.com/document/doi/10.1515/cclm-2012-0488/html.

Title:
Sensitivity of CA 15-3, CEA and serum HER2 in the early detection of recurrence of breast cancer
Description:
Background: The aim of this project was to investigate the sensitivity of CA 15-3, CEA and HER2 in the early diagnosis of metastatic breast cancer. Methods: Serial serum values of CA 15-3, CEA and HER2 were determined in 107 patients with recurrence after breast cancer. Fifteen of the patients had primary disseminated disease, nine patients only developed local recurrence during the follow-up period and the remaining 83 developed distant metastases. Results: In the group of patients with distant metastatic disease (n=83), elevated serum levels of CA 15-3 (>32.4 U/mL), CEA (>2.5 µg/L for non-smokers and >10 µg/L for smokers) and HER2 (>15 µg/L) were found in 49.4%, 38.6% and 32.5%, respectively, at the time of diagnosis of recurrence. CA 15-3 was significantly better than HER2 (p=0.027). The most sensitive combination was obtained using CA 15-3/CEA (60.2%) or CA 15-3/HER2 (57.8%). Combining all three tumour markers raised the sensitivity to 63.9%. In the subgroup of patients with tissue HER2+ tumours, the sensitivity of HER2 increased to 55.6%. The best combination in this group was CEA/HER2 (66.7%). In the subgroup of patients with tissue HER2− tumours, CA 15-3 was significantly better. The best combination was CA 15-3/HER2 or CA 15-3/CEA with a sensitivity of 55.8% and 59.6%, respectively. Conclusions: The combination of several tumour markers enhances the sensitivity for detection of metastatic breast cancer. We recommend HER2 or the combination of CEA and HER2 in tissue HER2+ and CA 15-3 or the combination of CA 15-3 and CEA in tissue HER2−.
Website Age:
1 years and 8 months (reg. 2023-10-11).

Matching Content Categories {📚}

  • Health & Fitness
  • Education
  • Science

Content Management System {📝}

What CMS is degruyterbrill.com built with?

Custom-built

No common CMS systems were detected on Degruyterbrill.com, but we identified it was custom coded using Bootstrap (CSS).

Traffic Estimate {📈}

What is the average monthly size of degruyterbrill.com audience?

🌍 Impressive Traffic: 500k - 1M visitors per month


Based on our best estimate, this website will receive around 600,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Degruyterbrill.com Make Money? {💸}

We can't tell how the site generates income.

Websites don't always need to be profitable; some serve as platforms for education or personal expression. Websites can serve multiple purposes. And this might be one of them. Degruyterbrill.com might be earning cash quietly, but we haven't detected the monetization method.

Keywords {🔍}

cancer, breast, google, scholar, search, cea, serum, patients, antigen, tumor, clinical, markers, res, recurrence, tumour, carcinoembryonic, followup, marker, study, clin, sensitivity, early, diagnosis, levels, human, monitoring, biol, detection, metastatic, disease, combination, tissue, anticancer, results, chem, oncol, molina, filella, carcinoma, evaluation, reference, article, laboratory, receptor, lab, protein, diseases, biomarkers, eur, treat,

Topics {✒️}

multiplexed-based technologies underlines heparin-induced thrombocytopenia due intensive post-operative follow nucleotide-binding oligomerization domain triple-negative breast cancer serum albumin assay prospective longitudinal study ivan brandslund published/copyright ann christina pedersen monitor blood glucose serial serum values routine oncology setting biological fluids performance cell free dna human tumor marker elevated serum levels article breast cancer thyroid nodules serum liver disease development invasive breast cancer sensitive tumor marker retrospective 6-year study complementary tumor maker jonna skov madsen john libbey eurotext isobm td-4 workshop el-nass sa hemolysis-resistant reagent large health check china glycoproteomic identification sox17 dna methylation pseudothrombocytopenia delta check cost effective algorithm conditions legal notice serum tumor markers primary disseminated disease distant metastatic disease metastatic breast cancer breast cancer advances localised breast cancer recurrent breast cancer operable gastric cancer patricia diana sørensen erik hugger jacobsen research support played breast carcinoma tissues journal clinical chemistry lópez-bueno mj del campo jm breast cancer recurrences

Questions {❓}

  • Have an idea on how to improve our website?
  • How does access work?
  • Multicenter reference intervals studies: a promising perspective for the future?
  • Serum tumor markers in breast cancer: are they of clinical value?

Schema {🗺️}

Article:
      author:
            type:Person
            name:Ann Christina Pedersen
            type:Person
            name:Patricia Diana Sørensen
            type:Person
            name:Erik Hugger Jacobsen
            type:Person
            name:Jonna Skov Madsen
            type:Person
            name:Ivan Brandslund
      editor:
      audience:
      datePublished:2013-07-01
      headline:
      keywords:keyword,keyword,keyword,keyword,keyword,keyword
      isAccessibleForFree:
      publisher:
         type:Organization
         name:De Gruyter
      context:https://schema.org
      name:Sensitivity of CA 15-3, CEA and serum HER2 in the early detection of recurrence of breast cancer
      image:https://www.degruyterbrill.com/document/cover/journal_key/CCLM/thumbnail
      url:https://doi.org/10.1515/cclm-2012-0488
Person:
      name:Ann Christina Pedersen
      name:Patricia Diana Sørensen
      name:Erik Hugger Jacobsen
      name:Jonna Skov Madsen
      name:Ivan Brandslund
Organization:
      name:De Gruyter

External Links {🔗}(88)

Analytics and Tracking {📊}

  • Google Analytics
  • Google Tag Manager

Libraries {📚}

  • Bootstrap
  • Clipboard.js

Emails and Hosting {✉️}

Mail Servers:

  • degruyterbrill-com.mail.protection.outlook.com

Name Servers:

  • ns-1335.awsdns-38.org
  • ns-1776.awsdns-30.co.uk
  • ns-379.awsdns-47.com
  • ns-617.awsdns-13.net
4.47s.